Three-year safety and effectiveness of fixed-dose losartan/ hydrochlorothiazide combination therapy in japanese patients with hypertension under clinical setting (PALM-1 extension study)

Clinical and Experimental Hypertension

Volumn 34, Issue 7, 2012, Pages 498-503

  Kita, Toshihiro ^a   Yokota, Naoto ^b   Ichiki, Yoshinari ^c   Ayabe, Takao ^d   Etoh, Takuma ^e   Tamaki, Noboru ^f   Kato, Johji ^a   Eto, Tanenao ^g   Kitamura, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b Yokota Naika   (Japan)

^c Ichiki Naika Geka Iin   (Japan)

^d Ayabe Iin   (Japan)

^e Etoh Clinic   (Japan)

^f Tamaki Clinic   (Japan)

^g Miyazaki Prefectural Health Foundation   (Japan)

Author keywords

Hydrochlorothiazide; Hypertension; Japanese; Losartan; Uric acid

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; PREMINENT; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERURICEMIA; HYPOKALEMIA; HYPOTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; STEADY STATE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; DIURETICS; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84870451696     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2012.666606     Document Type: Article

References (16)

1. Ogihara T, Kikuchi K, Matsuoka H, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32:3-107.
2. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
3. Ohkubo T, Obara T, Funahashi J, et al. Control of blood pressure as measured at home and office, and comparison with physicians' assessment of control among treated hypertensive patients in Japan: first report of the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Hypertens Res 2004; 27:755-763.
4. Kita T, Yokota N, Ichiki Y, et al. One-year effectiveness and safety of open-label losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension uncontrolled with ARBs or ACE inhibitors. Hypertens Res 2010; 33: 320-325.
5. Kamura A, Inoue T, Kuroki S, et al. Antihypertensive treatment using an angiotensin receptor blocker and a thiazide diuretic improves patients' quality of life: The Saga Challenge Antihypertensive Study (S-CATS). Hypertens Res 2011; 34:1288-1294.
6. Ito H, Ishii K, Kihara H, et al. Adding thiazide to a reninangiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension. Hypertens Res 2012; 35:93-99.
7. Shiga Y, Miura S-I, Mitsutake R, Uehara Y, Inoue A, Saku K. Effect of fixed-dose losartan/hydrochlorothiazide on brain natriuretic peptide in patients with hypertension. J Renin Angiotensin Aldosterone Syst 2012; 13:107-112.
8. Mori H, Ukai H, Yamamoto H, et al. Current status of antihypertensive prescription and associated blood pressure control in Japan. Hypertens Res 2006; 29:143-151.
9. Brown IJ, Tzoulaki I, Candeias V, Elliott P. Salt intakes around the world: implications for public health. Int J Epidemiol 2009; 38:791-813.
10. Ohta Y, Tsuchihashi T, Onaka U, Eto K, Tominaga M, Ueno M. Long-term compliance with salt restriction in Japanese hypertensive patients. Hypertens Res 2005; 28: 953-957.
11. Moser M, Setaro JF. Resistant or difficult-to-control hypertension. N Engl J Med 2006; 355:385-392.
12. Murai K, Obara T, Ohkubo T, et al. Current usage of diuretics among hypertensive patients in Japan: the Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Hypertens Res 2006; 29:857-863.
13. Ohshiro K, Sakima A, Nakada S, et al. Beneficial effect of switching from a combination of angiotensin II receptor blockers other than losartan and thiazides to a fixed dose of losartan/hydrochlorothiazide on uric acid metabolism in hypertensive patients. Clin Exp Hypertens 2011; 33: 565-570.
14. Shiga Y, Miura S, Morii J, et al. Comparison of the efficacy and safety of single-pill fixed-dose combinations of losartan/ hydrochlorothiazide and valsartan/hydrochlorothiazide in patients with hypertension (SALT-VAT study). Intern Med 2011; 50:2477-2483.
15. Borghi C, Veronesi M, Dormi A, Prandin MG, Cosentino E, Strocchi E. Persistence of treatment and blood pressure control in elderly hypertensive patients treated with different classes of antihypertensive drugs. Am J Geriatr Cardiol 2007; 16: 280-286.
16. Iwanaga T, Sato M, Maeda T, Ogihara T, Tamai I. Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter. J Pharmacol Exp Ther 2007; 320:211-217.